Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Genomtec financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
ZŁ8.6
2024-10-29
Market Capitalization
ZŁ114.6 M
2024-10-29
Revenue
ZŁ21 K
FY, 2025
CreditSafe Score
?
Score changed on Jun 12, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| PLN | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|
| Revenue | 20.0K | 219.0K | 40.0K | 1.0K | 1.0K | 21.0K |
| Cost of goods sold | 3.1M | 5.6M | 5.8M | 8.2M | 5.9M | 5.5M |
| Gross profit | 517.0K | (1.8M) | (5.3M) | (6.7M) | (3.4M) | (887.0K) |
| Gross profit margin, % | 2585.0% | -809.6% | -13282.5% | -675000.0% | -341400.0% | -4223.8% |
| Operating expense total | 2.1M | 4.7M | 5.4M | 746.0K | 5.3M | 6.5M |
| Depreciation and amortization | 244.0K | 504.0K | 826.0K | 1.3M | 2.3M | 2.8M |
| EBITDA | (1.6M) | (6.5M) | (10.7M) | (7.5M) | (8.7M) | (7.4M) |
| EBITDA margin, % | -7945.0% | -2963.9% | -26665.0% | -749600.0% | -873100.0% | -35109.5% |
| EBIT | (1.8M) | (7.0M) | (11.5M) | (8.8M) | (11.1M) | (10.2M) |
| EBIT margin, % | -9165.0% | -3194.1% | -28730.0% | -881100.0% | -1106100.0% | -48447.6% |
| Interest income | 3.0K | 64.0K | 73.0K | 84.0K | ||
| Interest expense | 73.0K | 28.0K | 292.0K | 236.0K | 134.0K | 306.0K |
| Pre tax profit | (1.9M) | (7.1M) | (11.9M) | (9.0M) | (11.2M) | (10.5M) |
| Income tax expense | (214.0K) | 5.0K | 46.0K | (18.0K) | 20.0K | (33.0K) |
| Net Income | (1.7M) | (7.1M) | (11.9M) | (9.0M) | (11.2M) | (10.4M) |